ASD Archives | Cannabiz

Neurotech opens US pathway for NTI164 after FDA clearance

by Adam Sheldon July 14, 2026July 15, 2026

Neurotech International has received Investigational New Drug (IND) clearance from the US Food and Drug Administration […]

News in brief: Vitura signs MedReleaf deal; Neurotech initiates first site for Phase 3 autism trial

by Adam Sheldon March 17, 2026June 8, 2026

Cannabinoid Oil In Laboratory - Medical Cannabis Australia - Cannabiz

Family experience of MC drives Medibis to fund autism anxiety trial

by Adam Sheldon August 5, 2025August 19, 2025

Medibis embarks on fresh capital raise ahead of autism clinical trial

by Steve Jones February 23, 2024February 28, 2024

Company news: Neurotech; AusCann

by Steve Jones January 25, 2024July 16, 2024